Why We Need to Be Talking About Vaccines That Offer “Mucosal Immunity”
September 13, 2022
(Axios) – As the U.S. rolls out updated mRNA-based COVID shots, a growing chorus of experts say it’s a mistake not to focus on treatments that boost immunity through mucous membranes. Why it matters: Next-generation nasal or oral vaccines could quickly boost the immune response in the very airways where COVID-19 enters the body and ultimately break our reliance on the constant development of reformulated shots to target new variants of concern. (Read More)